Status:
COMPLETED
Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
Lead Sponsor:
Aerie Pharmaceuticals
Conditions:
Glaucoma, Open-Angle
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To evaluate the IOP lowering efficacy of netarsudil ophthalmic solution 0.02% when used as monotherapy or when used concomitantly with other IOP-lowering agents in subjects with elevated IOP due to op...
Eligibility Criteria
Inclusion
- Key
- Male or female subjects (aged 18 or older)
- Subjects diagnosed with open-angle glaucoma or ocular hypertension, and determined by the treating physician to require additional intraocular pressure (IOP)-lowering treatment with netarsudil 0.02%.
- Willingness to follow protocol requirements, including signed informed consent, routine follow-up schedule, completing questionnaires and completing laboratory tests
- Key
Exclusion
- Have any active ocular disease other than glaucoma or ocular hypertension that would interfere with study interpretation
- Women of childbearing potential who are pregnant, nursing, or planning a pregnancy and not using a medically acceptable form of birth control. Male subjects with a female partner of childbearing potential must have had a prior vasectomy or agree to use an effective method of birth control during the treatment period and for 3 months after the subject has completed the study.
- Known sensitivity or allergy to the study medication or components
- Any systemic disease or clinical evidence of any condition which would make the subject, in the opinion of the investigator, unsuitable for the study or could potentially confound the study results
- Concurrent participation or prior participation in any investigational drug or device study within the last 30 days prior to the Baseline Visit
Key Trial Info
Start Date :
December 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2019
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT03808688
Start Date
December 27 2018
End Date
July 26 2019
Last Update
September 29 2020
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Atlantis Eyecare
Huntington Beach, California, United States, 92647
2
Harvard Eye Associates
Laguna Hills, California, United States, 92653
3
North Bay Eye Associates, Inc
Petaluma, California, United States, 94954
4
Shettle Eye Research Inc
Largo, Florida, United States, 33773